Abstract

Objective: To determine the ultrastructural findings on Rectal Mucosa (RM) of patients with HIV/AIDS and anorectal pathologies (ARP), at micrometric and nanometric scales. Materials and methods: 5 patients were evaluated, 18 - 55 years old, with ARP (HIV co-infection with HPV, n = 4, and HIV-negative patient with HPV infection) (control n = 1), who were referred to the Coloproctology Unit of the HUC, and subjected to rectoscopy and biopsy. RM samples were identified, placed in a sterile plastic bottle with 1 mL of 2% glutaraldehyde and immediately transported for routine processing of fine cut (60 - 90 nm) to be evaluated via Transmission Electron Microscopy (TEM). They were fixed with Karnovsky solution with Millonig phosphate buffer (pH 7.4 and 320 mOsm) and post-fixed with OsO4 under the same conditions of pH and osmolarity. Results: Ultrastructural findings, at 10−6 scale: 1) Intestinal mucosa: vacuoles of mucus of different sizes that seem to be fused. 2) Smooth muscle cells: loss of definition of contractile myofilaments mass. 3) Unmyelinated axons and terminals of Schwann cells (SC): Edema and loss of their plasma membranes in some areas of association with axon terminals as well as abundant collagen fibers associated with SC. Ultrastructural findings, at 10−9 scale: 1) Smooth muscle cells: folded wrapper cores and edema of mitochondria and rough endoplasmic reticulum cisterns (RER). 2) Myelinated axon terminals: Loss of synaptic vesicles. 3) Fibroblasts: One observes mitochondria and cisterns of RER with alterations. All these alterations can generate intestinal and anorectal dysfunction in these patients. Conclusions: The HIV causes changes in rectal and muscular mucosa despite HAART treatment with undetectable viral load.

Highlights

  • Gastrointestinal pathologies/disorders (GI) are common during the course of human immunodeficiency virus (HIV) infection. 35% of patients have GI symptoms as clinical presentation of HIV

  • We evaluate the ultrastructural findings, at micrometric and nanometric scales, in rectal and muscular mucosa of patients with HIV/AIDS and anorectal pathologies in order to achieve a better understanding of this pathology and a therapeutic directed to target with perspectives to upgrade the quality of life

  • The characteristics of the patients who participated in the study are described in the following table: FEATURES OF PATIENT WITH HIV/AIDS (n = 4) AGE

Read more

Summary

Introduction

Gastrointestinal pathologies/disorders (GI) are common during the course of HIV infection. 35% of patients have GI symptoms as clinical presentation of HIV. The intestinal mucosa (IM) plays an important role in the pathogenesis as well as a persistent HIV area despite the fact that Highly Active Antiretroviral Therapy (HAART) is effective [9] [10]. Previous research has shown that viral replication remains in lymphoid tissue for at least two years despite the fact that HAART has achieved complete suppression of viral load in peripheral blood. This demonstrates incomplete suppression of viral replication as well as the increased activation of the immune system and persistent intestinal inflammation at the level of the IM [14]. Increased expression of intestinal P-gp may reduce the absorption of drugs that are substrates of P-gp and may result in reduced bioavailability and subtherapeutic plasma levels [15]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call